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ABSTRACT
Premenstrual Dysphoric Disorder (PMDD) is the most severe form of Premenstrual Syndrome (PMS). It impacts 
the lives and productivity of women worldwide. The literature review found eight studies conducted on PMS and 
menstruation in Malaysia. However, none of these studies focused on PMDD and  reported the utilization of psy-
chometrically valid and reliable tools in assessing it.  One of the common measures used to assess PMDD is Daily 
Record of Severity of Problems (DRSP). Items in DRSP are based on the Diagnostic and Statistical Manual of Mental 
Disorders, Fifth edition. Currently, there are two published studies on the validation of DRSP and its psychometric 
properties which will be discussed in this paper.  The review shows that an ongoing adaptation and validation study 
of DRSP among Malaysian is being conducted. This will contribute to the body of knowledge regarding PMDD in 
local settings. 
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Premenstrual Dysphoric Disorder (PMDD) is the most 
severe disorder within the  Premenstrual Syndrome 
(PMS) spectrum (1). This spectrum of disorders is a 
combination of psychological and physical symptoms 
that commence about a week before menstruation. 
These symptoms often subsides during the menses 
and disappear after that (2). These symptoms include 
irritability, anger, mood swings, depression, tension/
anxiety, abdominal bloating, breast pain, and fatigue 
(3,4). In this light, while PMS is manifested more as 
physical symptoms (5), PMDD is characterised by 
prominently moody symptoms (3,6). 
It was reported that PMDD affects about 3% to 8% of 
women in the Western population (3,7–9) while studies 
in Africa reported a higher prevalence rate of 26.8% to 
36.1% among their population (10,11).  Studies also 
found that the prevalence of PMDD is between 1.2% to 
6.4% among Asian women (12,13). 
Past studies suggested that there is no single aetiology 
of PMDD (3,14). On the other hand,  other studies 
revealed multifactorial predispositions towards the 
condition,  which includes biological and psychological 
factors (15,16). 
Biologically, several studies reported that hormonal 
changes that took place during the menstrual cycle of 
individuals with PMDD affects the neurotransmitter 
activities in the brain,  Gamma-aminobutyric acid 
(GABA) and serotonin (15–18). This disrupts mood and 
cognition of the sufferer, which may lead to anxiety and 
depression (16,18). A recent study reported that the cells 
of patients with PMDD have a characteristically different 
reaction when exposed to menstrual hormones, as 
opposed to women without PMDD (19). These finding 
at a cellular level support the notion that PMDD is 
hereditary. From the psychological perspective, it was 
postulated that women with a history of trauma and 
abuses like child abuse, sexual abuse, and other life 
threatening situations like physical attacks (20–24) are 
more at risk in developing PMDD  (20–23). 
It was reported that women suffering from this mood 
disorder may experience the symptoms  for up to 3.8 
years of their reproductive years (8). Women with 
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PMDD  demonstrate the similar  flawed marital and 
parental relationships, as women with recurrent or 
chronic clinical depression (8). While another study 
reported that PMDD sufferers were less effective in the 
workplace, and may spent less hours or missing from 
their workplace (25). 
The economic burden of depression in the United states 
of America (USA) reached up to tens of billions of dollars 
every year, and the value is expected to increase (26). This 
burden would encompass PMDD, as it is included as a 
unipolar depressive disorder. A study in South America 
reported that the average cost of burden for PMDD was 
up to 1618 BRL (Brazilian Real) (approximately 400 US 
Dollars) per patient per year (14). While another study 
implied that the economic burden of PMDD is related to 
decrease in productivity rather than health-care services 
or the absence from work-related costs (25). 
For treatment, a combination of pharmacological and 
non-pharmacological approach was suggested. Selective 
serotonin reuptake inhibitors (SSRIs) are the first line 
of pharmacological treatment for PMDD (18). While 
diet modification, exercise, and cognitive behavioural 
therapy (CBT) are among the non-pharmacological 
interventions recommended (6,27,28). It was also 
implied that by combining both kind of measures, the 
effect may at least contribute up to 50% reductions in 
the disease severity (2).
In view of the occurrence of this ailment worldwide, 
the purpose of this article is to review the local studies 
on PMDD and the common measures used to assess 
the disorder. Other than that, the study aims to review 
the validation studies of Daily Record of Severity of 
Problems (DRSP), one of the common measures used to 
assess PMDD.
PREMENSTRUAL DYSPHORIC DISORDER IN 
MALAYSIA
Literature search was performed using the university 
online databases and the Google Chrome search engine. 
The keywords used were “Premenstrual Dysphoric 
Disorder”, “PMDD”, “Premenstrual Syndrome”, 
“PMS”, “Malaysia” and “psychometric”. The literature 
found were scrutinized and reviewed by two clinical 
psychologists with wide experiences in adaptation and 
validation studies, as well as depressive disorders. Based 
on the literature search, there were eight studies on PMS 
or menstrual-related aspects or symptoms found (29–
36). However, no study found have focuses primarily on 
cases of PMDD in Malaysia.  
From the eight studies on PMS, four studies reported 
the prevalence of PMS and menstrual-related symptoms 
among university and college students (29,32,35,36). 
Another study stated the prevalence of premenstrual 
symptoms among a sample of women in rural areas 
and their methods of remedying it (33). Two studies 
were on attitudes and perceptions towards menses 
and PMS among the adolescent populations (30,31). 
Another study discussed the knowledge and attitudes 
towards menstrual disorders among premarital course 
participants in a north-eastern state in Peninsular 
Malaysia (34). A summary of the studies is presented in 
Table I. 
It was found that four studies utilized different measures 
to assess PMS among their samples (29,31,32,36). 
Two of the measures were based on American College 
of Obstetricians and Gynecologists (ACOG)’s PMS 
diagnostic criteria  (29,32). No psychometric properties 
or validation procedures of the instruments used to 
assess PMS were reported in these studies. Hence, the 
valid local prevalence rate of PMS and PMDD reported 
may be questionable. 
Three studies mentioned PMDD (29,32,33). Two of 
these studies concluded the prevalence rate of PMDD 
was between 0% to 7% among their samples (29,32). 
Although the utilisation of validated measures was not 
reported in these studies, this number is comparable 
with the prevalence rate previously reported among 
the Western population (3% to 8%) (3,7–9) and other 
Asian population (1.2% to 6.4%) (12,13). Meanwhile, 
another study indicated the possibility of undiagnosed 
PMDD among samples suffering  severe premenstrual 
symptoms (33).
Some of the authors argued that PMS and menstrual 
related symptoms affect the respondents’ functions, daily 
activities, and social relationships (32,33,35,36). Three 
studies implied the lack of health seeking behaviours 
related to PMS (30,33,36). All these studies indicate the 
inadequate knowledge about PMS and menstruations 
among the local samples, despite the relatively 
high prevalence of PMS (range from 37% to 69.7%) 
(29,31,32,36). These authors further recommended that 
actions should be planned to educate local populations 
on PMS or menstruation related symptoms, as well as to 
promote appropriate health seeking behaviours.
ASSESSMENTS OF PREMENSTRUAL DYSPHORIC 
DISORDER
Like other medical and psychiatric disorders, PMDD 
diagnostic process usually involves history taking, 
physical examinations, and objective assessments (i.e., 
psychological measures) of the patient (3,15,37,38). In 
adhering to the diagnostic criteria of PMDD in DSM-
5, a prospective daily rating of symptoms for at least 
two menstrual cycles was recommended (3,4,37,39). A 
daily self-rated measure of the symptoms is the preferred 
method, compared to everyday visits to professional 
personnel to examine the symptoms, as it is more 
convenient as well as being more time and cost saving. 
132Mal J Med Health Sci 15(2): 130-136, Jun 2019
Table I: Summary of studies about Premenstrual Syndrome (PMS) and menstrual-related aspects in Malaysia






en attending a 
rural primary care 
clinic (33) 
To assess the prevalence 
and severity of premenstrual 
symptoms of women in rural 
area, the associated factors 
and the practice for remedy. 
Participants were 158 women at a rural primary 
care clinic in Hulu Langat, Selangor, Malaysia. 
Premenstrual symptoms and severity were 
assessed using the SPAF.
Any remedy to relieve their symptoms were also 
recorded. 
75% reported at least one of the 
premenstrual symptoms.
Around 60% of the women did 
not use any remedy to reduce 
their premenstrual symptom(s). 
PMDD criteria was not 
assessed. 
Premenstrual symptoms were common 
and affected them physically and 
emotionally. 
Participants with severe symptoms 
could have PMDD and may benefit 
from medication.
Primary care providers to take an 
active role in identifying, educating, 
and managing premenstrual symptoms 
among women. 








To investigate attitudes 
toward menstruation, men-
strual symptoms, PMS, their 
impact and treatment-seeking 
behaviours of rural adoles-
cent girls in Malaysia.
Participants were 1,295 secondary school 
students age 13-19 years old from Pasir Mas and 
Rantau Panjang, Kelantan were given question-
naire to assess the objectives of the study. 
63.1% have PMS.
61.1% viewed PMS as normal 
part of menstrual cycle.
No relationship between atti-
tude and severity of symptoms.  
There is a need to educate the girls of 
these age group on how to manage 
symptoms of PMS and how to seek 
treatment. 








To explore the in-depth un-
derstanding of perceptions, 
impacts, and treatment seek-
ing on menstruation-related
issues from an ethnically 
mixed group of rural and 
urban girls.
27 focus group discussions (172 participants), 
age 13-19 years old from schools in Kuala 
Lumpur and Kelantan.
Many participants had less 
knowledge on menstruation, 
thus, menarche was a shock 
to them. 
Participants interpreted their 
PMS and dysmenorrhea as part 
of normal menstruation, so 
they do not seek appropriate 
treatment.
Education on menstruation, PMS and 
other menstrual related conditions 
would be useful to build positive 
attitudes towards menstruation 
related matter at home, school, and 
community.





To determine the prevalence 
of PMS and to investigate its 
associated factors.
211 medical students asked to fill ACOG’s 
PMS-criteria-based questionnaire and how it 
affects their daily functioning. 
51.65% had PMS. 
No significant relationships 
between symptoms of PMS 
with daily activities and func-
tionality. 
No student diagnosed with 
PMDD according to DSM-IV.
Women of reproductive age should 
be educated on PMS, so they could 
seek appropriate treatment to reduce 
their PMS. 
Future study on PMS should be inte-
grated with the services of follow-up 
and consultations to minimize the 
effects of the disorder.








To compare the knowledge 
and attitude between men 
and women among premar-
ital course participants on 
menstrual disorders.
430 participants answered the questionnaire. 
The questionnaire consisted of sociodemograph-
ic profile, knowledge, and attitude on menstrual 
disorders. 
Psychometric properties of the questionnaire: 
1. Content validity performed by obstetric and   
    gynaecologist, family medicine specialist, 
medical    
    statistician expert and Islamic religious 
teacher. 
2. Face validity was conducted on 10 respon-
dents. 
3. Internal consistency (α = 0.6-0.89).
Woman had more knowledge 
and more positive attitudes 
towards menstrual disorders 
than men.
Both men and women had low knowl-
edge on menstrual disorders, but men 
knew less. 
Plan should be constructed to:
•	 educate both men and 
women regarding menstrual disorders
•	 promote appropriate 
health seeking behaviours.
6. Study of 
PMS among 






To determine the prevalence 
of PMS, common Premen-
strual Syndrome symptoms, 
impairment of life, social 
and emotional well beings, 
and coping methods among 
students.
300 female students were recruited. 
Instrument was adapted from the PSST with 
addition on 6 items about coping and family 
history of PMS. 
37% had PMS based on 
ACOG-based criteria.
7% of the sample was diag-
nosed with PMDD (based on 
DSM-IV). 
PMS was more severe with 
younger age group, stressful 
lifestyles, academic stress, and 
sleeping problems. 
PMS is quite prevalent. 
Education on PMS should be con-
structed to:
•	 increase awareness of 
the disorder 
•	 provide a better coping 











To study the prevalence 
of menstrual disturbance, 
factors related to it, and the 
effect of participants’ daily 
activities.
Participants were 292 undergraduate students 
from a private medical college in Melaka. 
Instruments consisted of self-administered ques-
tionnaire sociodemographic profile, menstrual 
symptoms during menstruation, and treatment 
seeking behaviours. 
Pain from dysmenorrhea was assessed from the 
scale of 0 (no pain) to 10 (worst pain).
Effect from the symptoms was assessed using 
Born-Steiner Irritability Scale. 
69.5% had dysmenorrhea.
84.9% had premenstrual 
symptoms. 
The daily routine activities
were affected in 52.7% of 
respondents. 
Dysmenorrhea and premenstrual 
symptoms were quite prevalent among 
participants and affected their routines 
and social relationships.
 
To establish school-based counselling 
to educate the students in managing 





and quality of life 
among female




To study the association 
between PMS and quality 
of life, to identify common 
medical and psychiatric 
symptoms of PMS, and how 
the participants managed 
their symptoms.
Participants were 300 female students. 
Instruments consisted of questionnaire on 
sociodemographic profile, obstetrical history, 
symptoms of PMS, and its’ management. SF-36 
was utilized to measure quality of life. 
The prevalence of PMS was 
69.7%. 
8.3% had a severe form of 
PMS. 
The symptoms of PMS affected 
the quality of life of the par-
ticipants. 
PMS is prevalent among the selected 
population, but untreated. 
Appropriate support should be 
constructed for the sufferer of this 
condition as it may affect their quality 
of life.
Notes:
SPAF = Shortened Premenstrual Assessment Form; ACOG = American College of Obstetricians and Gynecologists; PSST = Pre-Menstrual Severity Screening Tool; DSM-IV: Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition; SF-36 = Short form Health Survey
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Some of the  common measures to assess PMDD and 
PMS include  Daily Record of Severity of Problems 
(DRSP)  (37), Premenstrual Symptoms Screening Tool 
(PSST) (40), Calendar of Premenstrual Experiences 
(COPE) (41), PRISM Calendar (Prospective Record of 
the Impact and Severity of Menstrual symptoms) (42), 
Self-Rating Scale for Premenstrual Assessment Form 
(PAF) (43,44), and the Premenstrual Tension Syndrome 
(PMTS) Rating Scales (45,46). All of these measures have 
adequate and satisfactory psychometric properties. The 
comparisons between these measures are summarized 
in Table II.
DRSP is one of the most widely used prospective daily 
self-rated measures to assess both PMS and PMDD 
(1,3,4,15,39,47). Initially, DRSP was developed based 
on the criteria of PMDD stated in the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition 
Table II: Comparison between common measures to assess Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Syndrome (PMS)
No Instrument
(order based on year of 
latest publication)
Objective & Use Items & Scale Psychometric Property Other Information & Limitation
1. Daily Records of Severity 
of Problems (DRSP) (37)
For diagnosis of PMS and 
PMDD, and monitoring 
symptoms severity through 
prospective daily rating.
21 items on PMDD symptoms 
and 3 items on individual 
functioning.
Likert scale 1 to 6 (the higher 




Validity indexes are satisfactory.
Items of DRSP are based on DSM-5 diagnostic 
criteria of PMDD. DRSP can be downloaded 
online and used with permission from the orig-
inal author readily.
2. Premenstrual Symptoms 
Screening Tool (PSST) (40)
For screening of PMS and 
PMDD through one-time 
rating.
14 items on PMS/PMDD symp-
toms and 5 items on individual 
functioning.
4 points Likert scale from “Not 
at all” to “Severe”.
Internal consistency 
(α = 0.91-0.93).
Validity indexes are satisfactory.
PSST is useful and convenient for screening, 
but not for the diagnosis or monitoring of the 
symptoms’ severity for PMS and PMDD.
3. Calendar of Premenstrual 
Experiences (COPE) (41)
For diagnosis of PMS and 
PMDD, and monitoring 
symptoms severity through 
prospective daily rating.
22 items of premenstrual 
distress symptoms.
Daily self-rating. 
Likert scale 0 to 3 (higher rating, 
more severe the symptoms).
Test-retest (r = 0.78).
Validity indexes are satisfactory.
Items were constructed based on the ACOG 
criteria of PMS, thus the usage is more for PMS, 
rather than PMDD.
4. PRISM Calendar (Prospec-
tive Record of the Impact 
and Severity of Menstrual 
symptoms) (42)
For diagnosis of PMS and 
PMDD, and monitoring 
symptoms’ severity through 
prospective daily rating.
23 items of PMS/PMDD 
symptoms.
Likert scale 0 to 3 (higher rating, 
more severe the symptoms).
Recent literature did not report 
psychometric property. Howev-
er, this measure had been used 
in various clinical trials and 
practices.
It was noted that some of the items did not re-
flect PMDD diagnostic criteria in DSM-5 (i.e., 
bowel activity) and certain items required more 
effort to rate (i.e., weight measurement after 
emptying the bladder before breakfast).
5. Self-Rating Scale for Pre-
menstrual Assessment Form 
(PAF) (43, 44)
To assess changes in mood, 
behaviour, and physical con-
dition during the pre-menses, 
through retrospective rating. 
Patient is required to rate 
their symptoms from about 7 
days before the onset of men-
ses to the time it started.  
Long form – 95 items.
Short form – 10 items.
Likert scales 1 to 6 (from “no 
change” to “extreme change”).
Internal consistency 
(α = 0.69-0.91).
Validity indexes are satisfactory.
Given the nature of retrospective administra-
tion and item’s construction (based on litera-
ture and established questionnaires on depres-
sion, anxiety, and premenstrual distress), PAF 
is useful for differentiating between clinical 
population of PMS or PMDD with non-clinical 
population, but not for the diagnosis of PMS or 
PMDD.
6. The Premenstrual Tension 
Syndrome (PMTS) Self-Rat-
ing Scales (45, 46)
For diagnosis of PMS and 
PMDD, and monitoring 
symptoms severity through 
prospective daily rating (for 
Self-Rating version).
The self-rating version contains 
36 items on PMS/PMDD 
symptoms.
Dichotomous items (Yes or No).
Items constructed based on 
interviews and other established 
questionnaires on menstrual 
symptoms.
Other versions: Observer rating 
form (11 items) and Visual 




Validity indexes are satisfactory.
PMTS-SR had been used in numerous studies 
and clinical trials related to PMS and PMDD. 
However, it was noted that some of the items 
did not reflect PMDD diagnostic criteria in 
DSM-5 (i.e., changes in hand writing and 
clumsiness). 
Furthermore, a dichotomous rating scale used 
in this measure provide limited range of de-
scription for severity of symptoms, as com-
pared to wider range/point Likert scale. 
The VAS form is more sensitive in detecting 
symptoms’ changes in severity.
Notes:
DSM-5 = Diagnostic and Statistical Manual, Fifth edition; ACOG = American College of Obstetricians and Gynecologists
(DSM-IV) (in section “depressive disorder not otherwise 
specified”) (37). Currently, the items are noted to adhere 
with the DSM-5 diagnostic criteria of PMDD (3).
Twenty-one items in DRSP measure physical and 
psychological symptoms related to the menstrual 
cycle, and three items measure the dysfunctionality 
related to daily routines, hobbies or social activities, 
and relationship with others. A six-point scale,  ranging 
from 1 (Not at all) to 6 (Extreme) was used to rate the 
symptoms. Despite its wide use in both clinical and 
research practices (1,4,8,37,39,48), only two published 
studies found  have analysed the DRSP’s psychometric 
properties (37,39).
VALIDATION STUDIES OF DRSP
The original study presented the development of DRSP 
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among the United States samples (37), and the second 
highlighted the adaptation and validation of DRSP among 
nursing students in China (39). Generally, both studies 
demonstrated good reliability and validity indexes. Table 
III presents  a summary of the psychometric properties of 
both studies.
In both studies (37,39), the respondents were required 
to make daily ratings for at least two menstrual cycles. 
For the purpose of discussion here, the values from these 
studies (37,39) have been described in range (taken from 
both of menstrual phases: luteal and follicular phases), 
and based on the  total items score, rather than each 
factors or groups score (except for internal consistency 
for each factors in the Chinese study).
The original study (37) was divided into two studies: 
study A and study B. For study A, the respondents were 
27 individuals whose symptoms ranged from no or few 
premenstrual problems to having PMDD, while for 
study B, the  respondents included 243 samples who 
fulfilled the PMDD criteria stated in  the Diagnostic and 
Statistical Manual of Mental Disorder, fourth edition 
(DSM-IV) (37). 
It was found that the reliability indexes for study A and 
study B ranged from good to excellent, with internal 
consistency (α = 0.93 to 0.96) and test-retest (r = 0.73 
to 0.99) (37). The validity indexes in the original study 
revealed that DRSP correlated satisfactorily with the 
criterion measures: depressive measure and impairment 
in social situation measure (concurrent validity, r = 
0.38 to 0.75), and inversely correlated with different 
construct measure: quality of life and satisfaction 
measure (divergent validity, r = -0.44) (37). 
Meanwhile, the original study did not report exploratory 
Table III: Summary of psychometric properties of the original and other validation study on the Daily Record of Severity of Problems (DRSP)







27 respondents range 
from who had no or few 
menstrual problems to 
PMDD.
Study B:
243 respondents met 
























HDRS               
(r = 0.75) 
Study B
HDRS 
(r = 0.38), 
SAS (r = 0.45)
EFA was not performed. How-
ever, the authors theoretically 
classified the items into 3 
groups in the data analysis: 
(a) Depressive Symptoms 






Chinese sample: 126 
nursing students in 
university at urban area 
in China
α = 0.96-0.97
F1, α = 0.96-0.97
F2, α = 0.87-0.89
F3, α = 0.66-0.84
F4, α = 0.73-0.90
r = 0.84 PMTS-SR
(r = 0.43-0.45)
 Not available SDS 
(r = 0.43-0.55)
Exploratory factor analysis: 4 
factors, 75.63% accounted 
variance. 
F1 (Mood): 12 items (34.5%)
F2 (Behaviour): 5 items 
(18.51%)
F3 (Pain): 2 items (11.81%)
F4 (Physical): 2 items (10.80%)
Notes: DSM-IV: Diagnostic and Statistical Manual of Mental Disorder, fourth edition; F: Factor; HDRS: Hamilton Depression Rating Scale; PMTS-SR: Premenstrual Tension Syndrome Self-Rating; 
Q-LES-Q: Quality of Life Enjoyment and Satisfaction Questionnaire; SAS: Social Adjustment Scale; SDS: The Zung Self-Rating Depression Scale
* The values of reliability and validity indexes were utilized from the total score of items in each study.
factor analysis (37). However, the authors  have classified 
21 items on physical and psychological symptoms of 
PMDD in DRSP into three theoretical groups in the 
data analysis, including (a) depressive symptoms (b) 
physical symptoms (c) anger/irritability (37). The authors 
also reported that DRSP is able to measure less severe 
premenstrual symptoms and the changes of severity over 
the cycle (37). Moreover,  for clinical purposes, DRSP is 
able to detect changes in PMDD symptoms with at least 
two types of treatment (37).
The second validation study was conducted among 
Chinese female nursing students in China (39). It was 
found that the validity indexes for this study are excellent 
with  internal consistency (α = 0.96 to 0.97) and test-
retest (r = 0.84) (39). The validity indexes in the study 
showed that the Chinese version of DRSP correlated 
satisfactorily with the convergent measure: measure 
to assess PMS/PMDD (convergent validity, r = 0.43 – 
0.45), and the criterion measure: depressive measure 
(concurrent validity, r = 0.43 to 0.55) (39). 
The Chinese study also reported exploratory factor 
analysis of the Chinese version of DRSP (39). It showed 
four factor structures with 75.6% accounted variance 
(Factor 1 (Mood) - 12 items (34.5% variance), Factor 2 
(Behaviour) - 5 items (18.51% variance), Factor 3 (Pain) 
- 2 items (11.81%) and Factor 4 (Physical) - 2 items 
(10.80%)) (39).  The internal consistency for each factor 
ranged from moderate to excellent (α = 0.66 to 0.97) 
(39).
CURRENT PROGRESS IN MALAYSIA
Currently, a series of ongoing adaptation and validation 
studies for psychological measures assessing PMDD 
are being conducted. The Daily Records of Severity 
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of Problems (DRSP) has been chosen for adaptation 
and validation based on its adherence to the DSM-5 
diagnostic criteria of PMDD. The objective of this study 
is to determine the reliability index, validity index, and 
factor structure of the Malay adapted version of DRSP. 
CONCLUSION
From the review, it can be concluded that little is known 
about PMDD in Malaysia. This could be due to a limited 
number of local studies in this field, in addition to the 
lack of validated measure to assess PMDD among 
the Malaysian population. Hence, the ongoing study 
is meant to address this situation by taking the initial 
step in adapting and validating tool(s) to assess the 
disorder. Previous findings showed that despite PMDD 
is a debilitating condition, it is relatively manageable. 
Considering the significant burden and impacts of this 
disorder, it is hoped that the outcome of this study could 
encourage further local research in this field. 
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